2m 2m 2m 2m 2m 2m 2m
Fresenius Sp.ADR (FMS)
NYSE
$23.71+$0.31 (+1.35%)
Price as of Jun 23, 2026 5:57 PM EDT- $12.6BMarket Cap
- -10.37%1-Year Change
- Medical Care FacilitiesIndustry
Fresenius Sp.ADR (FMS)
$23.71+$0.31 (+1.35%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 19.6B +1.51% | 19.3B -0.61% | 19.5B +0.29% | 19.4B +10.10% | |
Cost of Revenue | 14.6B +0.13% | 14.6B +0.35% | 14.5B +3.13% | 14.1B +12.33% | |
Gross Profit | 5.0B +5.72% | 4.8B -3.42% | 4.9B -7.25% | 5.3B +4.59% | |
Sales and Marketing Expense | 3.0B -3.50% | 3.1B -1.67% | 3.2B -15.54% | 3.8B +22.24% | |
Research and Development Expense | -158.0M -13.91% | -183.5M -20.90% | -232.0M -201.46% | 228.6M +3.55% | |
Depreciation and Amortization Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Operating Expenses | 3.0B -3.50% | 3.1B -1.67% | 3.2B -15.54% | 3.8B +22.24% | |
Operating Profit | 1.8B +31.22% | 1.4B +1.68% | 1.4B -9.41% | 1.5B -18.38% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -375.2M -4.60% | -393.3M -6.55% | -420.9M +17.24% | -359.0M +4.42% | |
Interest Income and Expense and Net | -375.2M -4.60% | -393.3M -6.55% | -420.9M -217.24% | 359.0M +4.42% | |
Total Nonoperating Income and Expense | 528.1M -30.52% | 760.1M +47.52% | 515.2M +43.52% | 359.0M +4.42% | |
Income before Taxes | 1.2B +60.79% | 740.9M +1.15% | 732.5M -18.10% | 894.3M -26.64% | |
Income Taxes | 321.0M +1.56% | 316.1M +5.16% | 300.6M -7.51% | 325.0M -7.90% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 1.2B +60.79% | 740.9M +1.15% | 732.5M -18.10% | 894.3M -26.64% | |
Net Income from Continuing Operations Applicable to Common | 1.2B +60.79% | 740.9M +1.15% | 732.5M -18.10% | 894.3M -26.64% | |
Basic EPS and Net Income | 3.36 +83.61% | 1.83 +7.65% | 1.70 -26.09% | 2.30 -30.51% | |
Diluted EPS and Net Income | 3.36 +83.61% | 1.83 +7.65% | 1.70 -26.09% | 2.30 -30.51% | |
Basic Weighted Average Shares | 291.2M -0.76% | 293.4M 0.00% | 293.4M +0.06% | 293.2M +0.10% | |
Diluted Weighted Average Shares | 291.2M -0.76% | 293.4M 0.00% | 293.4M +0.06% | 293.2M +0.10% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 1.6B +35.50% | 1.2B -15.91% | 1.4B +10.18% | 1.3B -14.03% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 1.6B +35.50% | 1.2B -15.91% | 1.4B +10.18% | 1.3B -14.03% | |
Total Current Assets | 7.9B -0.31% | 7.9B -8.95% | 8.7B +6.07% | 8.2B +2.96% | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | 3.5B -4.38% | 3.6B -3.61% | 3.8B -8.91% | 4.2B -1.94% | |
Total Long-Term Assets | 23.1B -9.90% | 25.6B +1.65% | 25.2B -8.43% | 27.6B +4.36% | |
Total Assets | 31.0B -7.64% | 33.6B -1.07% | 33.9B -5.10% | 35.8B +4.04% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | 2.1M -99.54% | 456.9M -31.70% | 669.0M -46.73% | |
Total Current Liabilities | 6.2B +10.34% | 5.7B -7.39% | 6.1B -5.50% | 6.5B -10.89% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 10.5B -13.71% | 12.1B -6.57% | 13.0B -6.11% | 13.8B +5.39% | |
Total Liabilities | 16.7B -6.06% | 17.8B -6.83% | 19.1B -5.92% | 20.3B -0.41% | |
Retained Earnings | 12.2B +8.36% | 11.3B +3.16% | 10.9B +1.96% | 10.7B -1.06% | |
Total Stockholders Equity | 14.3B -9.42% | 15.8B +6.35% | 14.8B -4.03% | 15.4B +10.52% | |
Total Shares Outstanding | 279.3M -4.81% | 293.4M 0.00% | 293.4M 0.00% | 293.4M +0.14% | |
Cash Flow | |||||
Cash from Operating Activities | 2.7B +12.36% | 2.4B -9.23% | 2.6B +21.29% | 2.2B -12.94% | |
Capital Expenditures | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | -722.5M +750.65% | -84.9M -84.39% | -544.2M -25.93% | -734.7M -38.58% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -1.4B -45.39% | -2.6B +38.24% | -1.9B +14.91% | -1.6B +57.89% | |
Financials Ratio | |||||
Gross Margin | 25.62% +4.15% | 24.60% -2.83% | 25.32% -7.52% | 27.38% -5.00% | |
Operating Margin | 9.31% +29.26% | 7.20% +2.30% | 7.04% -9.67% | 7.79% -25.87% | |
Return on Assets | 3.69% +68.08% | 2.20% +4.43% | 2.10% -17.59% | 2.55% -30.89% | |
Return on Equity | 7.93% +63.70% | 4.84% +0.09% | 4.84% -20.39% | 6.08% -34.41% | |
Revenue Growth | 1.51% +349.31% | -0.61% -311.13% | 0.29% -97.16% | 10.10% +850.30% | |
Current Ratio | 1.26 -9.65% | 1.40 -1.69% | 1.42 +12.25% | 1.27 +15.54% | |
Cash Ratio | 0.26 +22.83% | 0.21 -9.19% | 0.23 +16.55% | 0.20 -3.53% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow